| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 04/03/2003 | WO2003027074A1 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders |
| 04/03/2003 | WO2003027061A2 Muscarinic agonists |
| 04/03/2003 | WO2003026666A1 2-phenylamino-4- (5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, as src kinase inhibitors |
| 04/03/2003 | WO2003026665A1 2-phenylamino-4-(5-pyrazolylamino)-pyrimidine derivatives as kinase inhibitors, in particular, src kinase inhibitors |
| 04/03/2003 | WO2003026664A1 2-phenylamino-4- (5-pyrazolylamino) -pyramidine derivatives as kinase inhibitors, in particular, src kinase inhibitors |
| 04/03/2003 | WO2003026660A1 An enantiomerically pure diarylmethylpiperazine and methods of using same |
| 04/03/2003 | WO2003026648A1 4,5-dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity |
| 04/03/2003 | WO2003026647A1 Novel 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity |
| 04/03/2003 | WO2003026587A2 Compounds useful for treating hepatitus c virus |
| 04/03/2003 | WO2003002531A3 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 04/03/2003 | WO2003002530A3 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 04/03/2003 | WO2002100974A3 Core guest host system comprising a chromophore in a polycarbonate matrix |
| 04/03/2003 | WO2002092563A3 Protease inhibitors |
| 04/03/2003 | WO2002074738A3 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage) |
| 04/03/2003 | WO2002039954A3 Novel compounds |
| 04/03/2003 | WO2002013808A3 Treatment of tumors with acetylenes distributed with a phenyl or heteroaromatic group and a substituted chromanyl, thiochromanyl or tetrahydroquinolinyl group in combination with other anti-tumor agents |
| 04/03/2003 | US20030065200 Taxanes having T-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them |
| 04/03/2003 | US20030065187 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 04/03/2003 | US20030065179 Diabetic therapy |
| 04/03/2003 | US20030065176 Anticoagulant; cardiovascular disorders |
| 04/03/2003 | US20030065034 Antiinflammatory agents; coupling sulfonyl halide with aromatic amine compound |
| 04/03/2003 | US20030065012 Estrogen receptor modulators |
| 04/03/2003 | US20030065007 Analgesics; psychological disorders; antidepressants |
| 04/03/2003 | US20030065004 Androgen receptor modulators and methods for use thereof |
| 04/03/2003 | US20030064997 Novel compounds |
| 04/03/2003 | US20030064992 N-aryl (thio) anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 04/03/2003 | US20030064982 Pyrazole compounds useful as protein kinase inhibitors |
| 04/03/2003 | US20030064981 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 04/03/2003 | US20030064980 Respiratory system disorders; antiinflammatory agents |
| 04/03/2003 | US20030064977 Viricides |
| 04/03/2003 | US20030062509 Field effect transistor, OLED, electroluminescent device, RFID tag, backlight, photovoltaic or sensor device, or electrophotographic recording device; security marking; charge injection layer, planarising layer, antistatic film |
| 04/03/2003 | CA2461709A1 Small organic molecule regulators of cell proliferation |
| 04/03/2003 | CA2461363A1 Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors |
| 04/03/2003 | CA2461360A1 3-pyridyl or 4-isoquinolinyl thiazoles as c17,20 lyase inhibitors |
| 04/03/2003 | CA2461128A1 Pyrazole derivatives useful in the treatment of hyper-proliferative disorders |
| 04/03/2003 | CA2460000A1 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 04/02/2003 | WO2002030891A1 Aliphatic nitrogenous five-membered ring compounds |
| 04/02/2003 | EP1298496A2 Electrophotographic organophotoreceptors |
| 04/02/2003 | EP1298125A1 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 04/02/2003 | EP1296978A2 N-ureidoheterocycloaklyl-piperidines as modulators of chemokine receptor activity |
| 04/02/2003 | EP1296975A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 04/02/2003 | EP1296974A2 2-cyanopyrrolidine derivatives and their use as medicaments |
| 04/02/2003 | EP1296973A1 Guanidine derivatives of quinazoline and quinoline for use in the treatment of autoimmune diseases |
| 04/02/2003 | EP1296972A1 Arylmethylamine derivatives for use as tryptase inhibitors |
| 04/02/2003 | EP1296961A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 04/02/2003 | EP1296950A2 Aminopiperidines for use as glyt-1 inhibitors |
| 04/02/2003 | EP1296931A2 Polyamine analogues as cytotoxic agents |
| 04/02/2003 | EP1204668B1 Bisimidino compounds and the transitional metal complexes thereof as well as the use thereof as catalysts |
| 04/02/2003 | EP1135386B1 Method for producing pyrazolylbenzoyl derivatives and novel pyrazolylbenzoyl derivatives |
| 04/02/2003 | EP1015446B1 (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents |
| 04/02/2003 | EP0991643B1 Novel aminooxyamide tricyclic inhibitors of farnesylprotein transferase |
| 04/02/2003 | EP0951467B1 SUBSTITUTED NITROGEN CONTAINING HETEROCYCLES AS INHIBITORS OF p38 PROTEIN KINASE |
| 04/02/2003 | EP0912512B1 Sulphonamide derivatives and their use in the treatment of cns disorders |
| 04/02/2003 | EP0880504B1 Heterocyclo-substituted imidazoles for the treatment of inflammation |
| 04/02/2003 | EP0681574B1 C7 Taxane derivatives and pharmaceutical compositions containing them |
| 04/02/2003 | CN1407971A Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof |
| 04/02/2003 | CN1407970A Urea compounds having muscarinic receptor antagonist activity |
| 04/02/2003 | CN1406937A 1-[1-(hetero) aryl-1-perhydroxyalkylmethyl]-piperazine compound, preparation thereof and pharmaceutics containing it |
| 04/02/2003 | CN1104429C 4-(3-heterocycly-1-benzoyl) pyrazoles and their use as herbicides |
| 04/02/2003 | CN1104418C Benzoheterocyclic derivatives |
| 04/01/2003 | US6541638 (2S,4S)-1-(4-Mercapto-1-(naphthalene-2-sulfonyl)-pyrrolidine-2 -carbonyl)-piperidine-4-carboxylic acid ethyl ester for example; zinc protease inhibitors; for treating diseases associated with vasoconstriction |
| 04/01/2003 | US6541505 Inhibiting the activity of Factor Xa; treating a disease state associated with a physiologically detrimental excess amount of thrombin. |
| 04/01/2003 | US6541491 4-mercaptopyrrolidine derivatives as farnesyl transferase inhibitors |
| 04/01/2003 | US6541489 Excellent inhibitory activity of one or more matrix metalloprotease (MMP) enzymes, such as MMP-2, MMP-9, and MMP-13, while exhibiting substantially less inhibition at least of MMP- 1 |
| 04/01/2003 | US6541477 Inhibitors of p38-a kinase |
| 04/01/2003 | US6541476 Piperazine derivatives and their use as anti-inflammatory agents |
| 04/01/2003 | US6541474 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia |
| 04/01/2003 | US6541470 Have a potent antiviral activity against picornaviruses and rotaviruses. |
| 04/01/2003 | US6541209 Bioassay; identification of compounds as agonists; use in treatment of diseases and disorders that are related to 5-HT2A and or 5-HT2C serotonin receptors |
| 03/27/2003 | WO2003024961A1 Insecticidal 3-(2,6-disubstituted phenyl)-5-[4- or 5-arylthien-2- or -3-yl]-1,2,4-triazoles |
| 03/27/2003 | WO2003024955A2 Small molecule inhibitors of caspases |
| 03/27/2003 | WO2003024954A1 Novel terthiophene-3-carboxylic acid compound and fabricating method thereof, functionalized conductive terthiophene polymer with the compound as a monomer, process for dna hybridizatioon detection using the polymer, and fabricating method of probe dna |
| 03/27/2003 | WO2003024950A1 Coumarin derivative |
| 03/27/2003 | WO2003024949A1 Dna-pk inhibitors |
| 03/27/2003 | WO2003024948A1 Benzofuran and dihydrobenzofuran derivatives useful as beta-3 adrenoreceptor agonists |
| 03/27/2003 | WO2003024935A2 Substituted pyrazolyl compounds for the treatment of inflammation |
| 03/27/2003 | WO2003024933A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same |
| 03/27/2003 | WO2003024929A1 Substituted piperidines with selective binding to histamine h3-receptor |
| 03/27/2003 | WO2003024926A2 Methods and compositions of novel triazine compounds |
| 03/27/2003 | WO2003024453A1 Excitatory amino acid receptor antagonists |
| 03/27/2003 | WO2003024451A1 2-(2-phenylethyl)-benzimidazole-5-carboxamide derivatives and their use as tryptase inhibitors |
| 03/27/2003 | WO2003024448A2 Inhibitors of histone deacetylase |
| 03/27/2003 | WO2003024441A1 Novel use of tricyclic compound |
| 03/27/2003 | WO2003024220A1 Delta 1-pyrrolines used as pesticides |
| 03/27/2003 | WO2002101007A3 Antipathogenic benzamide compounds |
| 03/27/2003 | WO2002078628A3 Cyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazapines as hiv reverse transcriptase inhibitors |
| 03/27/2003 | WO2002060879A3 Bacterial gyrase inhibitors and uses thereof |
| 03/27/2003 | WO2001092218A3 Polyamine analogues as therapeutic and diagnostic agents |
| 03/27/2003 | US20030060638 C7 carbamate substituted taxanes |
| 03/27/2003 | US20030060626 Fungicides |
| 03/27/2003 | US20030060474 A piperazine compound as antithrombotic agent |
| 03/27/2003 | US20030060473 Piperazine compounds as inhibitors of MMP or TNF |
| 03/27/2003 | US20030060461 Cyclic diamine compound with condensed-ring groups |
| 03/27/2003 | US20030060453 Such as 4-((4-fluorophenyl)hydrazono)-4H-pyrazole- 3,5-diamine for antiproliferative activity, and promoting apoptosis in cells lacking normal regulation of cell cycle and death |
| 03/27/2003 | US20030060452 N-heterocyclic derivatives as NOS inhibitors |
| 03/27/2003 | DE10207217C1 Production of 1,2-dichloroethane, used as intermediate for vinyl chloride, involves dissolving chlorine in circulating liquid medium containing catalyst and removing undissolved gas before contact with ethylene solution |
| 03/27/2003 | CA2465978A1 Inhibitors of histone deacetylase |
| 03/27/2003 | CA2461074A1 Methods and compositions of novel triazine compounds |
| 03/27/2003 | CA2460942A1 Substituted pyrazolyl compounds for the treatment of inflammation |
| 03/27/2003 | CA2460149A1 2-phenyl-3-heteroarylpropionic acid derivative or salt thereof and medicine containing the same |